These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2464401)

  • 1. The effect of MPTP on uridine uptake in murine nerve cells.
    Pakkenberg H; Pakkenberg B; Fog R; Eldrup E
    Brain Res; 1988 Sep; 460(1):146-9. PubMed ID: 2464401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on uridine uptake in the mouse brain.
    Pakkenberg H; Pakkenberg B; Kjeldsen C
    Brain Res; 1986 Jan; 362(1):192-4. PubMed ID: 3484652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) enhances tryptophan hydroxylase activity in mouse striatum, but not in the frontal cortex.
    Fukuda H; Hara K; Nakamura S; Kimura H; Kameyama M
    Brain Res; 1988 May; 449(1-2):399-402. PubMed ID: 2456132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS
    Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Neurosci Lett; 1985 Jul; 58(1):133-7. PubMed ID: 3876523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of neurotensin receptors in MPTP-treated mice.
    Tanji H; Araki T; Fujihara K; Nagasawa H; Itoyama Y
    Peptides; 1999; 20(7):803-7. PubMed ID: 10477079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.
    Sonsalla PK; Heikkila RE
    Eur J Pharmacol; 1986 Oct; 129(3):339-45. PubMed ID: 3490988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
    Ferraro TN; Golden GT; DeMattei M; Hare TA; Fariello RG
    Neuropharmacology; 1986 Sep; 25(9):1071-4. PubMed ID: 2430229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the MPTP-treated mouse as an animal model of parkinsonism.
    Heikkila RE; Sonsalla PK
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):436-40. PubMed ID: 3499967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute electrophysiological and neurochemical effects of administration of MPTP in mice.
    Studer A; Sundström E; Jonsson G; Schultz W
    Neuropharmacology; 1988 Sep; 27(9):923-31. PubMed ID: 3263584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.
    Yong VW; Perry TL; Krisman AA
    Neurosci Lett; 1986 Jan; 63(1):56-60. PubMed ID: 3485266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I; Asari S; Nishimoto A; Felten DL
    No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurometabolic profiles of the substantia nigra and striatum of MPTP-intoxicated common marmosets: An in vivo proton MRS study at 9.4 T.
    Heo H; Ahn JB; Lee HH; Kwon E; Yun JW; Kim H; Kang BC
    NMR Biomed; 2017 Feb; 30(2):. PubMed ID: 28028868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.